<DOC>
	<DOCNO>NCT01078233</DOCNO>
	<brief_summary>The main objective study monitor health outcomes associate antiretroviral drug population HIV-infected patient .</brief_summary>
	<brief_title>Observational Data Analysis EuroSIDA ( MK-0518-058 )</brief_title>
	<detailed_description>Time Perspective : Retrospective Prospective</detailed_description>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Adults 16 year old old HIV1 Subjects exclude prospective follow</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV</keyword>
	<keyword>antiretroviral treatment</keyword>
	<keyword>HIV Cohort</keyword>
	<keyword>Treatment</keyword>
</DOC>